A detailed history of Pro Share Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 120,117 shares of REGN stock, worth $85.8 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
120,117
Previous 113,211 6.1%
Holding current value
$85.8 Million
Previous $119 Million 6.12%
% of portfolio
0.32%
Previous 0.33%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $7.07 Million - $8.3 Million
6,906 Added 6.1%
120,117 $126 Million
Q2 2024

Aug 13, 2024

SELL
$883.2 - $1071.19 $10.6 Million - $12.8 Million
-11,992 Reduced 9.58%
113,211 $119 Million
Q1 2024

May 08, 2024

BUY
$902.69 - $993.35 $19.5 Million - $21.5 Million
21,604 Added 20.85%
125,203 $121 Million
Q4 2023

Feb 14, 2024

SELL
$775.18 - $881.7 $14 Million - $15.9 Million
-18,022 Reduced 14.82%
103,599 $91 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $8.99 Million - $11 Million
12,984 Added 11.95%
121,621 $100 Million
Q2 2023

Aug 10, 2023

SELL
$700.03 - $830.35 $4.08 Million - $4.84 Million
-5,831 Reduced 5.09%
108,637 $78.1 Million
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $6.66 Million - $8.09 Million
9,788 Added 9.35%
114,468 $94.1 Million
Q4 2022

Feb 02, 2023

SELL
$705.89 - $766.39 $10.5 Million - $11.4 Million
-14,924 Reduced 12.48%
104,680 $75.5 Million
Q3 2022

Nov 04, 2022

SELL
$573.97 - $724.32 $13.4 Million - $16.9 Million
-23,334 Reduced 16.32%
119,604 $82.4 Million
Q2 2022

Aug 01, 2022

SELL
$548.35 - $738.84 $35.2 Million - $47.4 Million
-64,197 Reduced 30.99%
142,938 $84.5 Million
Q1 2022

May 10, 2022

SELL
$595.12 - $698.43 $5.32 Million - $6.24 Million
-8,932 Reduced 4.13%
207,135 $145 Million
Q4 2021

Feb 08, 2022

BUY
$543.48 - $670.97 $34.7 Million - $42.9 Million
63,874 Added 41.97%
216,067 $136 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $9.44 Million - $11.2 Million
16,450 Added 12.12%
152,193 $92.1 Million
Q2 2021

Aug 13, 2021

SELL
$472.8 - $558.54 $2.03 Million - $2.4 Million
-4,301 Reduced 3.07%
135,743 $75.8 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $8.5 Million - $10.4 Million
19,031 Added 15.73%
140,044 $66.3 Million
Q4 2020

Feb 09, 2021

BUY
$478.3 - $607.98 $7.89 Million - $10 Million
16,493 Added 15.78%
121,013 $58.5 Million
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $10.2 Million - $12.3 Million
18,638 Added 21.7%
104,520 $58.5 Million
Q2 2020

Aug 03, 2020

BUY
$493.32 - $643.92 $5.9 Million - $7.7 Million
11,959 Added 16.18%
85,882 $53.6 Million
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $10.3 Million - $15.2 Million
-30,717 Reduced 29.35%
73,923 $36.1 Million
Q4 2019

Feb 12, 2020

SELL
$274.13 - $376.51 $121,165 - $166,417
-442 Reduced 0.42%
104,640 $39.3 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $791,119 - $921,102
2,893 Added 2.83%
105,082 $29.2 Million
Q2 2019

Aug 13, 2019

SELL
$299.6 - $414.82 $268,142 - $371,263
-895 Reduced 0.87%
102,189 $32 Million
Q1 2019

May 15, 2019

SELL
$372.08 - $439.57 $807,041 - $953,427
-2,169 Reduced 2.06%
103,084 $42.3 Million
Q4 2018

Feb 14, 2019

BUY
$335.82 - $403.04 $4.48 Million - $5.38 Million
13,338 Added 14.51%
105,253 $39.3 Million
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $6.27 Million - $7.29 Million
-17,851 Reduced 16.26%
91,915 $37.1 Million
Q2 2018

Aug 13, 2018

SELL
$284.6 - $344.99 $2.05 Million - $2.48 Million
-7,194 Reduced 6.15%
109,766 $37.9 Million
Q1 2018

May 14, 2018

BUY
$315.82 - $393.78 $41,056 - $51,191
130 Added 0.11%
116,960 $40.3 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $6.11 Million - $8.01 Million
17,043 Added 17.08%
116,830 $43.9 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $4.52 Million - $5.28 Million
10,478 Added 11.73%
99,787 $44.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
89,309
89,309 $43.9 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.